Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy. - Wikidata - awgldk - TriplyDB

Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy.

Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy.

http://www.wikidata.org/entity/Q35833912

about

A Mini-Review for Cancer Immunotherapy: Molecular Understanding of PD-1/PD-L1 Pathway & Translational Blockade of Immune Checkpoints A Critical Evaluation of Bifidobacterial Adhesion to the Host Tissue Novel perspectives on therapeutic modulation of the gut microbiota Gastrointestinal stem cells in health and disease: from flies to humans Cytokine-Induced Modulation of Colorectal Cancer Antagonizing programmed death-1 and programmed death ligand-1 as a therapeutic approach for gastric cancer High-content molecular profiling of T-cell therapy in oncology Recent advances in understanding antitumor immunity Host-Microbiome Interaction and Cancer: Potential Application in Precision Medicine The Gut Microbiome as Therapeutic Target in Central Nervous System Diseases: Implications for Stroke Gut Bifidobacteria Populations in Human Health and Aging The Impact of the Gut Microbiota on Drug Metabolism and Clinical Outcome Role of the Microbiota in Colorectal Cancer: Updates on Microbial Associations and Therapeutic Implications Resurrecting the intestinal microbiota to combat antibiotic-resistant pathogens PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations Cross-talk between microbiota and immune fitness to steer and control response to anti PD-1/PDL-1 treatment Genome Analysis and Characterisation of the Exopolysaccharide Produced by Bifidobacterium longum subsp. longum 35624™Gut microbiota and colorectal cancer.Canine cancer immunotherapy studies: linking mouse and human.Molecular pathological epidemiology: new developing frontiers of big data science to study etiologies and pathogenesis.The intestinal microbiome and surgical disease.Combined toll-like receptor 3/7/9 deficiency on host cells results in T-cell-dependent control of tumour growth Capsular polysaccharide inhibits adhesion of Bifidobacterium longum 105-A to enterocyte-like Caco-2 cells and phagocytosis by macrophages.Antioxidant Properties of Probiotic Bacteria.The Intestinal Eukaryotic and Bacterial Biome of Spotted Hyenas: The Impact of Social Status and Age on Diversity and Composition Neutrophils in the tumor microenvironment: trying to heal the wound that cannot heal.Message in a Bottle: Dialog between Intestine and Skin Modulated by Probiotics.Microbiota, Inflammation and Colorectal Cancer.Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy.Gut microbiota, inflammation and colorectal cancer.Manipulation of Innate and Adaptive Immunity through Cancer Vaccines.The Host Microbiome Regulates and Maintains Human Health: A Primer and Perspective for Non-Microbiologists.Tumour immunology: Intestinal bacteria are in command.A 'fit' microbiota to potentiate cancer immunotherapy The role of microbiota in cancer therapy.Intestinal microbiome analyses identify melanoma patients at risk for checkpoint-blockade-induced colitis.Tumor and Host Factors Controlling Antitumor Immunity and Efficacy of Cancer Immunotherapy.The complex interplay of diet, xenobiotics, and microbial metabolism in the gut: Implications for clinical outcomes.Signaling in Host-Associated Microbial Communities.The microbial pharmacists within us: a metagenomic view of xenobiotic metabolism

P2860

Q26738729-1FFCEC2F-809D-4A14-9BAB-59C2612BE36B Q26740150-37F9636F-0D66-4DA1-83DB-40AE781D87F4 Q26745706-EE6C08A5-56E0-4B5B-B957-4F911E4139B0 Q26750514-3F1B1AA8-363B-4F16-9A30-E804CC1E35A1 Q26752374-A02DA8B2-923B-4449-9210-8D680F0BFF99 Q28066532-5F037318-8E49-4D46-9642-FA91BF59F44E Q28066792-28F0A3E6-ED33-4EA3-8CAB-10BDC475B48F Q28067217-11A112EA-0F32-404F-8B61-ADD21F270082 Q28069401-94B84FF1-B07F-4CC4-BCBC-AF81DA4DC20F Q28069455-71E0EC60-D4A3-4DB4-8409-AC3159ADE19F Q28071697-05B5F74B-CCE6-4D64-999C-94A92DE24A55 Q28071938-ED4F13DF-1926-491B-9212-669662F8BDBC Q28073131-9AC92B47-1D16-4AD5-9186-EC270367B282 Q28075653-E30EE6CD-273F-4977-8D05-BB74EB679AC8 Q28075712-E2F16D15-339F-4C74-94BC-5411243DDED1 Q28076294-3D8B1426-3229-4798-98E9-C0EACF1EC5AC Q28554290-FBA04166-A2D7-4F05-81E7-CDC95280F54B Q30239806-7D33E5DF-7942-404E-BD02-573385D9E01E Q30239893-419AFA8C-6F22-4510-B79F-C672BB486483 Q30244608-A87EA462-00BE-4633-83AC-38A606C556DD Q30248605-765BB20D-86CA-4EBA-84A2-AB729C9F3396 Q30842176-341E549C-8E4C-4AB3-873C-FEF057972D8E Q33623573-D3076970-1889-4420-963A-609698AC1215 Q33749630-83A634D2-E7F7-43A8-A46B-BCE2827FE890 Q33804411-80D17821-5979-424A-A5A4-40BABC89D3DC Q33816141-1CD7AA4D-79AD-4090-A05E-3419F7AB197C Q33838310-3DA8833B-8F49-434B-B615-296577752A9A Q33839116-9C60ED83-184F-48B3-9EBE-DF5ED0CB4E85 Q34522172-8B4D31B7-1876-4F2A-ACDF-387AA8CC94E5 Q34549031-A261CE89-91A9-400E-9E50-511E02E0836D Q34552791-15B7ABD4-9141-4C07-84A0-95F81590C286 Q34553267-7362858C-7D76-4C64-BE47-D6B4D4DC5FBF Q35865880-26F3E8C2-0C56-4C30-B66E-0F8EFAF27FF0 Q35874071-86A2C75A-518A-482C-BAD7-2A5E2499794B Q35906938-9DF64294-CDFC-4C8D-8BC7-86826097E14C Q35912366-AE6C7C99-219E-49E5-B21B-DC8C6447BAFA Q35938555-0D78CB9F-CF57-4515-9F96-627BFD7C9155 Q35947598-99356F29-2939-4A21-9069-8F837FE36F74 Q35953810-74947F57-6AD5-4BB8-BB5A-BAD3F30C0677 Q35955534-785E2475-A611-4812-BEB2-0F63DD6D9AA4

P2860

Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy.

http://www.wikidata.org/entity/Q35833912

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Commensal Bifidobacterium prom ...... cilitates anti-PD-L1 efficacy.

@ast

Commensal Bifidobacterium prom ...... cilitates anti-PD-L1 efficacy.

@en

type

label

Commensal Bifidobacterium prom ...... cilitates anti-PD-L1 efficacy.

@ast

Commensal Bifidobacterium prom ...... cilitates anti-PD-L1 efficacy.

@en

prefLabel

Commensal Bifidobacterium prom ...... cilitates anti-PD-L1 efficacy.

@ast

Commensal Bifidobacterium prom ...... cilitates anti-PD-L1 efficacy.

@en

P1433

Q35833912-14AB529C-C5D9-460D-88DE-B5D1029C3E51

P1476

Q35833912-753A73CE-3143-4908-AA8E-0A2D816544C8

P2093

Q35833912-0E051D58-13E8-466B-8C7A-718AEC8B90E9

Q35833912-2139379D-BEB0-40E6-B55C-FA7982BE0EFC

Q35833912-27B2B0B1-0265-4D10-AAE2-6EABD0FAADBC

Q35833912-2A87E23D-D539-4AD9-9C49-BE5B745B247A

Q35833912-61C018DE-E1EC-4BFA-825D-C1F6D8431BB8

Q35833912-6694F6FA-2F3F-4FFC-AA99-45BE2AC26210

Q35833912-79C3F81A-45AE-4B67-8448-B434FF813269

Q35833912-8FFC20C4-2821-4A31-A01D-7D8C396044E9

Q35833912-B39055A7-CF92-49FD-9B31-E2406D1B0C4C

Q35833912-D488A2A5-EF40-4CB0-AABB-CA246BC4C8A4

P2860

Q35833912-00B3A774-56E2-4195-A195-3250C566FE67

Q35833912-11FA9E58-630D-4ABD-AAC2-3F5673D617FC

Q35833912-128FE7BB-1A0E-4CA6-A439-F336277C5461

Q35833912-178919F2-3D50-45CE-AB74-C58717C378C7

Q35833912-320EE879-E69F-4F95-BF7F-6834BAAE29CB

Q35833912-37D3754E-291A-4645-8752-BB75BB7615C1

Q35833912-3C2928B4-47CB-41EC-9FA8-FDE18A5C53AA

Q35833912-51C009BF-11E4-4A38-8214-C67CC6C4CCF2

Q35833912-558DA1FB-0D75-4770-8347-EAA91781E11D

Q35833912-5C72736E-6EFB-4E5F-BDDF-077F5BC43040

P304

Q35833912-EEFC9BB2-D87D-40B9-B2AB-0DE1F96D6338

P31

Q35833912-DF580B68-30D2-4C04-A2E2-C5499D4B0232

P356

Q35833912-2EE4B99E-AEC0-464F-8FBC-4C9D210FAF4F

P407

Q35833912-992A0BFB-6943-4617-912A-0EB500DDEB7E

P433

Q35833912-BFCC7AD4-0D46-499C-BB54-1196C0501053

P478

Q35833912-0CDBA870-0FCB-4E71-8DCA-1774D6935442

P577

Q35833912-5DFD77B7-8A76-40EF-8558-DBD657DF96B8

P5875

Q35833912-907212FC-2AE9-4267-BC59-8D291877FF4D

P698

Q35833912-125B71CF-B1C2-4C09-990D-E64A6528281D

P932

Q35833912-988E47C5-8CAC-46F1-9C44-81965042759C

P356

SCIENCE.AAC4255

P1433

P1476

Commensal Bifidobacterium prom ...... cilitates anti-PD-L1 efficacy.

@en

P2093

Ayelet Sivan

http://www.w3.org/2001/XMLSchema#string

Bana Jabri

http://www.w3.org/2001/XMLSchema#string

Eugene B Chang

http://www.w3.org/2001/XMLSchema#string

Franco W Benyamin

http://www.w3.org/2001/XMLSchema#string

Jason B Williams

http://www.w3.org/2001/XMLSchema#string

Keston Aquino-Michaels

http://www.w3.org/2001/XMLSchema#string

Leticia Corrales

http://www.w3.org/2001/XMLSchema#string

Maria-Luisa Alegre

http://www.w3.org/2001/XMLSchema#string

Nathaniel Hubert

http://www.w3.org/2001/XMLSchema#string

Thomas F Gajewski

http://www.w3.org/2001/XMLSchema#string

P2860

Interactions between the microbiota and the immune system

Safety and Tumor Responses with Lambrolizumab (Anti–PD-1) in Melanoma

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

Induction of intestinal Th17 cells by segmented filamentous bacteria

Host type I IFN signals are required for antitumor CD8+ T cell responses through CD8{alpha}+ dendritic cells

Slc11a1, formerly Nramp1, is expressed in dendritic cells and influences major histocompatibility complex class II expression and antigen-presenting cell function

Induction of colonic regulatory T cells by indigenous Clostridium species

The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis

Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer

Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation

P304

1084-1089

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1126/SCIENCE.AAC4255

http://www.w3.org/2001/XMLSchema#string

P407

P433

6264

http://www.w3.org/2001/XMLSchema#string

P478

350

http://www.w3.org/2001/XMLSchema#string

P577

2015-11-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

283544442

http://www.w3.org/2001/XMLSchema#string

P698

26541606

http://www.w3.org/2001/XMLSchema#string

P932

4873287

http://www.w3.org/2001/XMLSchema#string